Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06755047

3D Placental Volume in Placenta Accreta

3D Ultrasound Placental Volume and Vascular Indices Versus 2D Parameters for Diagnosis of Placenta Accreta Spectrum

Status
Recruiting
Phase
Study type
Observational
Enrollment
38 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

Placenta Accreta spectrum is a major obstetric disease nowadays. Different methods are used for antenatal diagnosis. In our study, investigators are aiming to compare 2 common ways for diagnosis, i.e; 3D Ultrasound and 2D with color Doppler.

Detailed description

The word placenta accreta spectrum disorders (PASD) implies an atypical implantation of the placenta into the uterine wall and has been used to express placenta accreta, increta and percreta. Placenta accreta is a placenta where the placental villi sick on directly to the myometrium. Placenta increta is a placenta where the placental villi attack into the myometrium and placenta percreta is a placenta where the villi invade through the myometrium and into serosa. No antenatal diagnostic method gives the clinician 100% assurance of either ruling in or ruling out the existence of placenta accreta. The definitive diagnosis of placental accreta spectrum is frequently ended postpartum on hysterectomy specimens when an area of accretion shows chorionic villi which make direct contact with the myometrium and absence of deciduae. Antenatal ultrasound is the method of choice used to establish the diagnosis and direct clinical management.The combined use of power Doppler with three dimensional (3D) ultrasound provides the possibility of quantifying moving blood within a volume of interest. Three indices are calculated, namely vascularization index (VI), flow index and vascularization flow index

Conditions

Interventions

TypeNameDescription
RADIATION3D Ultrasound3D placental volume and vascular indices
RADIATION2D ultrasound2D placental criteria of invasion and color Doppler

Timeline

Start date
2024-12-31
Primary completion
2025-04-01
Completion
2025-05-01
First posted
2025-01-01
Last updated
2025-01-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06755047. Inclusion in this directory is not an endorsement.